BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 63)

New antibiotic, Zevtera, launched in Germany for treatment of bacterial lung infections

By

PRESS RELEASE Basilea Pharmaceutica Ltd. announced  Friday that its broad-spectrum antibiotic, Zevtera® (ceftobiprole medocaril) has been launched in Germany. The European Centre for Disease Prevention...

Brilacidin granted QIDP designation to treat skin infections

By

Biopharmaceutical company, Cellceutix Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) designation for Brilacidin as...

University of Liverpool researchers find liposomes can neutralize bacterial toxins

By

PRESS RELEASE Researchers at the University of Liverpool have demonstrated a new treatment against antibiotic resistant bacterial infections. Published in Nature Biotechnology, the study showed that...

Preventing mother-to-child HIV transmission: Three-drug regimen more effective

By

For HIV-infected women in good immune health, taking a three-drug regimen during pregnancy prevents mother-to-child HIV transmission more effectively than taking one drug during pregnancy, another during...

Non-antibiotic treatment for MRSA, Staphefekt, developed by Dutch company

By

The Dutch company, Micreos, launched the first  bacteria-killing enzyme specific to Staphylococcus aureus, which is equally effective in killing methicillin-resistant Staphylococcus aureus (MRSA) as...

Single-Dose Brilacidin Comparable to 7-Days of Daptomycin in treating skin infections

By

Cellceutix Corporation, a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications, is pleased to announce positive top-line results...

Favipiravir effective at reducing and eliminating norovirus in mice: Cambridge researchers

By

An experimental drug currently being trialed for influenza and Ebola viruses could have a new target: norovirus, often known as the winter vomiting virus. A team of researchers at the University of Cambridge...

Ebola drug: Tekmira says limited supply of TKM-Ebola available in December

By

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, provides an update on its Ebola program. The Company is reporting it has commenced limited GMP manufacture...

Chronic hepatitis C virus drug, Harvoni, receives FDA approval

By

The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection. Harvoni is the first combination pill approved to...

Dallas Ebola patient, Thomas Eric Duncan, receiving Ebola investigational medication Brincidofovir

By

The first case of Ebola Virus Disease (EVD) to be confirmed in the United States, Liberian man, Thomas Eric Duncan remains in critical condition. His condition is stable, according to Texas Health...